TD Capital Management’s NEVRO CORP. NVRO Stock Holding History

TD Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-84,648	Closed	-$446K	–	718
2024 Q4	$315K	Hold	84,648	–	–	0.03%	85
2024 Q3	$473K	Hold	84,648	–	–	0.05%	69
2024 Q2	$713K	Hold	84,648	–	–	0.07%	58
2024 Q1	$1.22M	Hold	84,648	–	–	0.13%	49
2023 Q4	$1.82M	Hold	84,648	–	–	0.21%	43
2023 Q3	$1.63M	Hold	84,648	–	–	0.2%	42
2023 Q2	$2.15M	Buy	84,648 +80,000	+1,721%	+$2.31M	0.26%	42
2023 Q1	$168K	Hold	4,648	–	–	0.02%	96
2022 Q4	$184K	Hold	4,648	–	–	0.02%	87
2022 Q3	$217K	Hold	4,648	–	–	0.03%	82
2022 Q2	$204K	Hold	4,648	–	–	0.03%	80
2022 Q1	$336K	Hold	4,648	–	–	0.04%	70
2021 Q4	$377K	Buy	+4,648	New	+$466K	0.04%	64

Other funds holding NVRO

BCM

Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

TD Capital Management's NVRO Position: Q1 2025 in Review

TD Capital Management sold out of NEVRO CORP. (NVRO) in Q1 2025, closing a stake of 84,648 shares — an estimated $446K sold.

TD Capital Management first reported a position in NVRO in Q4 2021 and held it in 13 quarters. The position peaked at $2.15M in Q2 2023. 126 funds tracked by Wall St. Rank hold NVRO as of Q1 2025.

TD Capital Management reported no remaining NEVRO CORP. position as of Q1 2025 after selling out during the quarter.
TD Capital Management sold 84,648 NEVRO CORP. shares in Q1 2025, an estimated $446K.
TD Capital Management first reported a position in NEVRO CORP. in Q4 2021 and held it in 13 quarters.
TD Capital Management's NEVRO CORP. position peaked at $2.15M in Q2 2023.
126 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2025.

Based on TD Capital Management's 13F filing for Q1 2025, filed 14 May 2025.